Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Osiris Therapeutics, Inc. (OSIR)

« Back to company index

OSIR Chatter Timeline

Stock Ticker for OSIR

Most Active Tweeters for OSIR

No tweets found

Recent Tweets for OSIR

biotechfan20 @biotechfan20
$OSIR was profitable 4 of the last 5 quarters. Dotted line is a linear regression to display the trend. The loss… https://t.co/9mjg2WvIip
August 22nd 2018, 1:08am
eastvillagetwt @eastvillagetwt
RT @biotechfan20: @ColumbiaMD $OSIR Q2 $0.07 profit, 16% revenue growth (2XPY), efficacious products, no debt. Litigation effectively resol…
August 20th 2018, 11:08am
biotechfan20 @biotechfan20
$osir revenue growth quarter after quarter, year after year. Even while distracted the last 2 years. Relisted… https://t.co/65ls6GqP0j
August 18th 2018, 4:08pm
ThisLincolnian @ThisLincolnian
Head-To-Head Review: Osiris Therapeutics $OSIR & Amgen $AMGN https://t.co/9HkZzXFNd4
August 18th 2018, 12:08pm
biotechfan20 @biotechfan20
$MESO attracting attention this afternoon. Foreshadowing a milestone payment to $OSIR...?
August 17th 2018, 2:08pm
biotechfan20 @biotechfan20
TipRanks 100% Bullish on $OSIR https://t.co/2hx4ls7AnK
August 17th 2018, 11:08am
biotechfan20 @biotechfan20
@askUHC When will @UHC cover Grafix? $OSIR Grafix crushes $MDXG Epifix 63% vs 18% in complete wound closure. This… https://t.co/npg965DqY8
August 17th 2018, 10:08am
biotechfan20 @biotechfan20
@ColumbiaMD $OSIR Q2 $0.07 profit, 16% revenue growth (2XPY), efficacious products, no debt. Litigation effectively… https://t.co/HmfUtXiGuC
August 17th 2018, 10:08am
biotechfan20 @biotechfan20
@UHC @AskUHC National Institute of Health Care Excellence (UK) states (Page 203) Cure Rate of $OSIR "Grafix therapy… https://t.co/EJu8E7Yb8j
August 16th 2018, 11:08am
ZolmaxNews @ZolmaxNews
Osiris Therapeutics $OSIR vs. Amgen $AMGN Head-To-Head Contrast https://t.co/2MPqGflFFm
August 16th 2018, 5:08am
MareaInformativ @MareaInformativ
Mesoblast $MESO versus Osiris Therapeutics $OSIR Head to Head Review https://t.co/SxnNwWKQGM
August 15th 2018, 6:08pm
biotechfan20 @biotechfan20
$OSIR Q2 $0.07 profit on 16% revenue growth (2x 2017), efficacious products, no debt. Litigation effectively resolv… https://t.co/Cnj5NjmOah
August 14th 2018, 8:08pm
biotechfan20 @biotechfan20
$OSIR Grafix CRUSHES $MDXG Epifix 63% vs 18% in complete wound closure. Journal of Wound Repair & Regeneration https://t.co/nhv5vzRaQ1 …
August 14th 2018, 8:08pm
TheMarketsDaily @TheMarketsDaily
Analyzing Amgen $AMGN & Osiris Therapeutics $OSIR https://t.co/N1y4RBqimj
August 14th 2018, 2:08am
usindexlive @usindexlive
Davis-Rea LTD Has Trimmed Its Apple $AAPL Holding; OSIRIS THERAPEUTICS NEW $OSIR Shorts Down By 1.52% https://t.co/yaAtLTqnEr
August 12th 2018, 5:08am
biotechfan20 @biotechfan20
@WarrenBuffett 8-9-18 $OSIR Q2 $0.07 profit/share on 16% revenue growth (rev accelerating 2x 2017), efficacious pro… https://t.co/turtXc1VWG
August 9th 2018, 11:08am
biotechfan20 @biotechfan20
@Baltimoreworld 8-9-18 $OSIR is back! Q2 $0.07 profit/share on 16% revenue growth, efficacious products, no debt.… https://t.co/UJdynbTtiS
August 9th 2018, 11:08am
biotechfan20 @biotechfan20
@BaltSunMedia @HoCoMD 8-9-18 $OSIR is back! Q2 $0.07 profit/share on 16% revenue growth, efficacious products, no… https://t.co/yl6Khl0w13
August 9th 2018, 11:08am
biotechfan20 @biotechfan20
PE ratios are 127.65 for biotech per Stern/NYU. $OSIR $0.07 earnings suggests a PE of 33. Best kept secret on #NASDAQ.
August 9th 2018, 11:08am
biotechfan20 @biotechfan20
$OSIR Grafix crushes $MDXG Epifix 63% vs 18% in complete wound closure. Journal of Wound Repair & Regeneration https://t.co/nhv5vzRaQ1
August 9th 2018, 10:08am
biotechfan20 @biotechfan20
8-9-18 $OSIR Q2 $0.07 profit/share on 16% revenue growth (rev accelerating 2x 2017 rate), efficacious products, no… https://t.co/shRX6jBE3L
August 9th 2018, 10:08am
mikea1028 @mikea1028
$osir Earnings of .07 and growth of 17%. Nice solid quarter!
August 8th 2018, 5:08pm
Allstocknews @Allstocknews
$OSIR New Form 10-Q for Osiris Therapeutics, Inc. From our Stock News Alerts App
August 8th 2018, 4:08pm
Stock_News_Now @Stock_News_Now
$OSIR: New SEC Filing for OSIR: Form 10-Q (No. 0001558370-18-006769): https://t.co/JpLHdTKnaw
August 8th 2018, 4:08pm
bibeypost_stock @bibeypost_stock
Is OSIRIS THERAPEUTICS INC NEW $OSIR a Buy? The Stock Reported Less Sellers - https://t.co/DO2dEeh4Xa
August 8th 2018, 3:08pm
reurope_stock @reurope_stock
OSIRIS THERAPEUTICS INC NEW $OSIR Short Interest Decreased By 0.03% https://t.co/kW8ZOuc85C
August 8th 2018, 3:08pm
mmahotstuff1 @mmahotstuff1
What’s in OSIRIS THERAPEUTICS INC NEW $OSIR After Decline in Shorted Shares? - https://t.co/eh7HIhXq5t
August 8th 2018, 3:08pm
whatsonthorold2 @whatsonthorold2
Today OSIRIS THERAPEUTICS INC NEW $OSIR Reported Decrease in Shorted Shares - https://t.co/DjwzC7YE0g
August 8th 2018, 3:08pm
west_moreland @west_moreland
What’s Propelling OSIRIS THERAPEUTICS INC NEW $OSIR After Lower Shorts Reported? https://t.co/bseWVUbciB
August 8th 2018, 3:08pm
Fanob_stock @Fanob_stock
OSIRIS THERAPEUTICS INC NEW $OSIR Short Interest Decreased By 0.03% https://t.co/avwJ56JfSG
August 8th 2018, 3:08pm
MareaInformativ @MareaInformativ
Contrasting Osiris Therapeutics $OSIR & Mesoblast $MESO https://t.co/SxnNwWKQGM
August 8th 2018, 12:08am
dispatchtribune @dispatchtribune
Osiris Therapeutics $OSIR and AveXis $AVXS Head-To-Head Review https://t.co/OIiv5VJE6W
August 7th 2018, 4:08pm
EnterpriseLeade @EnterpriseLeade
Analyzing AveXis $AVXS & Osiris Therapeutics $OSIR https://t.co/cdMZhtV1Q7
August 7th 2018, 1:08pm
dailypoliticaln @dailypoliticaln
Osiris Therapeutics $OSIR and AveXis $AVXS Head to Head Contrast https://t.co/SvJbxrzprE
August 4th 2018, 1:08am
biotechfan20 @biotechfan20
$OSIR 62% vs control of 21% (standard of care), what does this suggest relative to MiMedx Epifix?… https://t.co/t94CHAp1km
August 2nd 2018, 9:08pm
carwizrd @carwizrd
RT @biotechfan20: $OSIR Grafix three times better than $MDXG EpiFix for complete wound closure. Journal of Wound Repair & Regeneration http…
August 2nd 2018, 1:08pm
biotechfan20 @biotechfan20
$OSIR Grafix three times better than $MDXG EpiFix for complete wound closure. Journal of Wound Repair & Regeneratio… https://t.co/XPD8hhoo6o
August 2nd 2018, 1:08pm
biotechfan20 @biotechfan20
$OSIR back on the #NASDAQ. Looking forward to Q2 results (breakeven or profit?), FDA approval of $MESO aGVHD soluti… https://t.co/odG048nvtx
August 2nd 2018, 8:08am
Adrian_H @Adrian_H
@UnknownPatriot7 One thing at a time. Nobody cares about $OSIR, and they'd better stay on the straight and narrow.
August 1st 2018, 11:08pm
UnknownPatriot7 @UnknownPatriot7
Given the $OSIR relist news today and $MDXG delist prospect, we have officially entered into a state of "pure karmi… https://t.co/bOkq6NMOpk
August 1st 2018, 11:08pm
StocksThatDoubl @StocksThatDoubl
https://t.co/uAcamNRUPt alerted stocks increasing as much as 1,800+%. SUBSCRIBE https://t.co/3w5gHpPzL8 $QUMU $OSIR… https://t.co/oA6jikBQYL
August 1st 2018, 10:08pm
TranscriptDaily @TranscriptDaily
Head-To-Head Analysis: Osiris Therapeutics $OSIR vs. AveXis $AVXS https://t.co/9sOSMKV1FH
August 1st 2018, 8:08pm
AmericanBanking @AmericanBanking
Head-To-Head Analysis: AveXis $AVXS vs. Osiris Therapeutics $OSIR https://t.co/D1YcVMoi3K #stocks
August 1st 2018, 8:08pm
MotherCabriniNY @MotherCabriniNY
@RabbiIssamar @GNWLive We have no beef with $OSIR and come in peace. $MDXG
August 1st 2018, 3:08pm
StockNewsNow @StockNewsNow
$OSIR Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018 https://t.co/2tGjB2wXV9
August 1st 2018, 11:08am
mikea1028 @mikea1028
RT @biotechfan20: Complete wound closure by $OSIR Grafix 3X better than $MDXG EpiFix Journal of Wound Repair & Regeneration https://t.co/nh…
August 1st 2018, 8:08am
GNWLive @GNWLive
Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018 $OSIR https://t.co/fnst5o3LiZ
August 1st 2018, 8:08am
odibro @odibro
$OSIR to Re-list on The Nasdaq Global Market at the market open today
August 1st 2018, 8:08am
biotechfan20 @biotechfan20
Complete wound closure by $OSIR Grafix 3X better than $MDXG EpiFix Journal of Wound Repair & Regeneration… https://t.co/XtsGzLdFLl
August 1st 2018, 7:08am
biotechfan20 @biotechfan20
July 31, 2018 Nasdaq letter to SEC re: $OSIR: https://t.co/Cc2knCHTJW
July 31st 2018, 11:07am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.